TNFα- and NF-κB-dependent induction of the chemokine CCL1 in human macrophages exposed to the atherogenic lipoprotein(a)

Life Sciences

Volumn 84, Issue 13-14, 2009, Pages 451-457

  N'Diaye, Monique ^a   Le Ferrec, Eric ^a   Kronenberg, Florian ^b   Dieplinger, Hans ^b   Le Vee, Marc ^a   Fardel, Olivier ^a,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c RENNES UNIVERSITY HOSPITAL   (France)

Author keywords

CCL1; Lipoprotein(a); Macrophages; NF B; TNF

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ALPHA NAPTHTOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CCL1 CHEMOKINE; CYCLOHEXIMIDE; FLAVONE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN A; MESSENGER RNA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL1 PROTEIN, HUMAN; LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; MACROPHAGE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; ATHEROSCLEROSIS; BINDING SITE; BIOSYNTHESIS; BLOOD; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; METABOLISM;

ATHEROSCLEROSIS; BINDING SITES; CELLS, CULTURED; CHEMOKINE CCL1; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIPOPROTEINS; MACROPHAGES; NF-KAPPA B; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61849172944     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.01.012     Document Type: Article

References (44)

1. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovascular Research 35 (1997) 2-3
2. Anuurad E., Boffa M.B., Koschinsky M.L., and Berglund L. Lipoprotein(a): A unique risk factor for cardiovascular disease. Clinics in Laboratory Medicine 26 (2006) 751-772
3. Azrolan N., Gavish D., and Breslow J.L. Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. Journal of Biological Chemistry 266 (1991) 13866-13872
4. Bandyopadhyay S.K., de La Motte C.A., and Williams B.R. Induction of E-selectin expression by double-stranded RNA and TNF-alpha is attenuated in murine aortic endothelial cells derived from double-stranded RNA-activated kinase (PKR)-null mice. Journal of Immunology 164 (2000) 2077-2083
5. Bernardini G., Spinetti G., Ribatti D., Camarda G., Morbidelli L., Ziche M., Santoni A., Capogrossi M.C., and Napolitano M. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood 96 (2000) 4039-4045
6. Boffa M.B., Marcovina S.M., and Koschinsky M.L. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: Mechanistic insights from animal models. Clinical Biochemistry 37 (2004) 333-343
7. Brewington R., Chatterji M., Zoubine M., Miranda R.N., Norimatsu M., and Shnyra A. IFN-gamma-independent autocrine cytokine regulatory mechanism in reprogramming of macrophage responses to bacterial lipopolysaccharide. Journal of Immunology 167 (2001) 392-398
8. Brown K.A., Sayasith K., Bouchard N., Lussier J.G., and Sirois J. Molecular cloning of equine 17beta-hydroxysteroid dehydrogenase type 1 and its downregulation during follicular luteinization in vivo. Journal of Molecular Endocrinology 38 (2007) 67-78
9. Ferrari R. The role of TNF in cardiovascular disease. Pharmacological Research 40 (1999) 97-105
10. Fless G.M., ZumMallen M.E., and Scanu A.M. Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). Journal of Biological Chemistry 261 (1986) 8712-8718
11. Fujiwara N., and Kobayashi K. Macrophages in inflammation. Current Drug Targets Inflammatory Allergy 4 (2005) 281-286
12. Galle J., Schneider R., Heinloth A., Wanner C., Galle P.R., Conzelmann E., Dimmeler S., and Heermeier K. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: Role of oxidative stress. Kidney International 55 (1999) 1450-1461
13. Grethe S., Ares M.P., Andersson T., and Porn-Ares M.I. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L). Experimental Cell Research 298 (2004) 632-642
14. Hankinson O. The aryl hydrocarbon receptor complex. Annual Review of Pharmacology and Toxicology 35 (1995) 307-340
15. Haque N.S., Fallon J.T., Pan J.J., Taubman M.B., and Harpel P.C. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood 103 (2004) 1296-1304
16. Haque N.S., Fallon J.T., Taubman M.B., and Harpel P.C. The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium. Blood 97 (2001) 39-45
17. Haque N.S., Zhang X., French D.L., Li J., Poon M., Fallon J.T., Gabel B.R., Taubman M.B., Koschinsky M., and Harpel P.C. CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation 102 (2000) 786-792
18. Harpel P.C., and Haque N.S. Chemokine receptor-8: Potential role in atherogenesis. Israel Medical Association Journal 4 (2002) 1025-1027
19. Hiscott J., Kwon H., and Genin P. Hostile takeovers: viral appropriation of the NF-kappaB pathway. Journal of Clinical Investigation 107 (2001) 143-151
20. Jovinge S., Hamsten A., Tornvall P., Proudler A., Bavenholm P., Ericsson C.G., Godsland I., de Faire U., and Nilsson J. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 47 (1998) 113-118
21. Klezovitch O., Edelstein C., and Scanu A.M. Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain. Journal of Biological Chemistry 276 (2001) 46864-46869
22. Lecureur V., Ferrec E.L., N'Diaye M., Vee M.L., Gardyn C., Gilot D., and Fardel O. ERK-dependent induction of TNFalpha expression by the environmental contaminant benzo(a)pyrene in primary human macrophages. FEBS Letters 579 (2005) 1904-1910
23. Li H., and Lin X. Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation. Cytokine 41 (2008) 1-8
24. Liu C.A., Wang C.L., Wang F.S., Huang H.C., Chuang H., Chen R.F., Tai F.Y., and Yang K.D. Higher spontaneous and TNFalpha-induced apoptosis of neonatal blood granulocytes. Pediatric Research 58 (2005) 132-137
25. McMillan B.J., and Bradfield C.A. The aryl hydrocarbon receptor is activated by modified low-density lipoprotein. Proceedings of the National Academy of Sciences of the United States of America 104 (2007) 1412-1417
26. N'Diaye M., Le Ferrec E., Lagadic-Gossmann D., Corre S., Gilot D., Lecureur V., Monteiro P., Rauch C., Galibert M.D., and Fardel O. Aryl hydrocarbon receptor- and calcium-dependent induction of the chemokine CCL1 by the environmental contaminant benzo[a]pyrene. Journal of Biological Chemistry 281 (2006) 19906-19915
27. Ng S.B., Tan Y.H., and Guy G.R. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. Journal of Biological Chemistry 269 (1994) 19021-19027
28. Pei X.H., Nakanishi Y., Inoue H., Takayama K., Bai F., and Hara N. Polycyclic aromatic hydrocarbons induce IL-8 expression through nuclear factor kappaB activation in A549 cell line. Cytokine 19 (2002) 236-241
29. Reblin T., Niemeier A., Meyer N., Willnow T.E., Kronenberg F., Dieplinger H., Greten H., and Beisiegel U. Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. Journal of Lipid Research 38 (1997) 2103-2110
30. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Molecular Immunology 38 (2002) 881-885
31. Samad F., Yamamoto K., and Loskutoff D.J. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. Journal of Clinical Investigation 97 (1996) 37-46
32. Selvan R.S., Zhou L.J., and Krangel M.S. Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. European Journal of Immunology 27 (1997) 687-694
33. Sinal C.J., and Bend J.R. Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells. Molecular Pharmacology 52 (1997) 590-599
34. Son D.S., and Rozman K.K. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines. Archives of Toxicology 76 (2002) 404-413
35. Thorp K.M., Southern C., Bird I.N., and Matthews N. Tumour necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells-Analysis of tumour necrosis factor-receptor interactions. Cytokine 4 (1992) 313-319
36. van Grevenynghe J., Monteiro P., Gilot D., Fest T., and Fardel O. Human endothelial progenitors constitute targets for environmental atherogenic polycyclic aromatic hydrocarbons. Biochemical and Biophysical Research Communications 341 (2006) 763-769
37. van Grevenynghe J., Rion S., Le Ferrec E., Le Vee M., Amiot L., Fauchet R., and Fardel O. Polycyclic aromatic hydrocarbons inhibit differentiation of human monocytes into macrophages. Journal of Immunology 170 (2003) 2374-2381
38. Vila-del Sol V., Diaz-Munoz M.D., and Fresno M. Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages. Journal of Leukocyte Biology 81 (2007) 272-283
39. Vogel C.F., and Matsumura F. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family. Biochemical Pharmacology 77 4 (2009) 734-745
40. Vogel C.F., Sciullo E., and Matsumura F. Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines. Biochemical and Biophysical Research Communications 363 (2007) 722-726
41. Wilson S.J., Leone B.A., Anderson D., Manning A., and Holgate S.T. Immunohistochemical analysis of the activation of NF-kappaB and expression of associated cytokines and adhesion molecules in human models of allergic inflammation. Journal of Pathology 189 (1999) 265-272
42. Yamawaki H., Lehoux S., and Berk B.C. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation 108 (2003) 1619-1625
43. Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesseling G., and Wouters E.F. Systemic effects of smoking. Chest 131 (2007) 1557-1566
44. Zhao R.Z., Chen X., Yao Q., and Chen C. TNF-alpha induces interleukin-8 and endothelin-1 expression in human endothelial cells with different redox pathways. Biochemical and Biophysical Research Communications 327 (2005) 985-992